The correlation between photosensitizers' membrane localization, membrane-residing targets, and photosensitization efficiency

Various tetrapyrroles act as photosensitizers by efficiently generating singlet oxygen. Hydrophobic or amphiphilic photosensitizers are taken up by cells and are usually located in various cellular lipid membranes. Passive uptake by a membrane depends on biophysical properties of the membrane, such as its composition, temperature, phase, fluidity, electric potential etc., as well as on the external solution's properties. Although the intrinsic lifetime of singlet oxygen in the membrane phase is 10-30 μs, depending on lipid composition, it escapes much faster out of the membrane into the external or internal aqueous medium, where its lifetime is <3 μs. Any damage that singlet oxygen might inflict to membrane constituents, i.e. proteins or lipids, must thus occur while it is diffusing in the membrane. As a result, photosensitization efficiency depends, among others, on the location of the sensitizer in the membrane. Singlet oxygen can cause oxidative damage to two classes of targets in the membrane: lipids and proteins. Depolarization of the Nernst electric potential on cells' membranes was observed, but it is not clear whether lipid oxidation is a relevant factor leading to abolishing the resting potential of cells' membranes and to their death. We present a study of the effect of membrane lipid composition and the dissipation of the electric potential that is generated across the membrane. We find a clear correlation between the structure and unsaturation of lipids and the leakage of the membrane, which can be caused by their photosensitized oxidization. We demonstrate here that when liposomes are composed of mixtures similar to natural membranes, and photosensitization is being carried out under usual PDT conditions, photodamage to the lipids is not likely to cause enhanced permeability of ions through the membrane, which could be a mechanism that leads to cell death.

[1]  D. Kessel,et al.  HEMATOPORPHYRIN and HPD: PHOTOPHYSICS, PHOTOCHEMISTRY and PHOTOTHERAPY , 1984, Photochemistry and photobiology.

[2]  M. Rodgers,et al.  Plasma membrane depolarization and calcium influx during cell injury by photodynamic action. , 1991, Biochimica et biophysica acta.

[3]  Z. Malik,et al.  Electric depolarization of photosensitized cells: lipid vs. protein alterations. , 1993, Biochimica et biophysica acta.

[4]  A. M. Olsen,et al.  The use of a derivative of hematoporphyrin in tumor detection. , 1961 .

[5]  Raymond Bonnett,et al.  Chemical Aspects of Photodynamic Therapy , 2000 .

[6]  P Baas,et al.  Photodynamic therapy: a promising new modality for the treatment of cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.

[7]  S. McLaughlin Electrostatic Potentials at Membrane-Solution Interfaces , 1977 .

[8]  L M Loew,et al.  Fluorometric analysis of transferable membrane pores. , 1985, Biochemistry.

[9]  J Moan,et al.  Intracellular localization of photosensitizers. , 1989, Ciba Foundation symposium.

[10]  I. Kochevar,et al.  Influence of dye and protein location on photosensitization of the plasma membrane. , 1994, Biochimica et biophysica acta.

[11]  T J Dougherty,et al.  PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.

[12]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[13]  Victor B. Loschenov,et al.  Photodynamic Therapy and Fluorescence Diagnostics , 2000 .

[14]  L. Kunz,et al.  Photofrin II Sensitized Modifications of Ion Transport Across the Plasma Membrane of an Epithelial Cell Line: I. Electrical Measurements at the Whole-Cell Level , 1998, The Journal of Membrane Biology.

[15]  Leslie M. Loew,et al.  Synthesis, spectra, delivery and potentiometric responses of new styryl dyes with extended spectral ranges , 2006, Journal of Neuroscience Methods.

[16]  G. Bock,et al.  Photosensitizing compounds : their chemistry, biology and clinical use , 1989 .

[17]  B. Henderson,et al.  Release of prostaglandin E2 from cells by photodynamic treatment in vitro. , 1989, Cancer research.

[18]  D. Kessel,et al.  Localization and Photodynamic Efficacy of Two Cationic Porphyrins Varying in Charge Distribution¶ , 2003 .

[19]  A. Girotti Lipid hydroperoxide generation, turnover, and effector action in biological systems. , 1998, Journal of lipid research.

[20]  L M Loew,et al.  Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential. , 1994, Biophysical journal.

[21]  W. Lands,et al.  Biochemistry and physiology of n‐3 fatty acids , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  T. Dubbelman,et al.  Plasma Membrane Properties Involved in the Photodynamic Efficacy of Merocyanine 540 and Tetrasulfonated Aluminum Phthalocyanine , 2000, Photochemistry and photobiology.

[23]  T. Obsil,et al.  The effect of hypericin and hypocrellin-A on lipid membranes and membrane potential of 3T3 fibroblasts. , 1999, Biochimica et biophysica acta.

[24]  E. Selke,et al.  Photosensitized oxidation of methyl linoleate: Secondary and volatile thermal decomposition products , 2006, Lipids.

[25]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[26]  M. Rodgers,et al.  DEPOLARIZATION OF MOUSE MYELOMA CELL MEMBRANES DURING PHOTODYNAMIC ACTION , 1990, Photochemistry and photobiology.

[27]  H. C. Robertson,et al.  Hematoporphyrin‐Derivative Fluorescence in Malignant Neoplasms , 1968, Journal of the South Carolina Medical Association.

[28]  Stanley B. Brown,et al.  Photosensitized inactivation of microorganisms , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[29]  Z. Malik,et al.  Destruction of erythroleukemia, myelocytic leukemia and burkitt lymphoma cells by photoactivated protoporphyrin , 1980, International journal of cancer.

[30]  Z. Malik,et al.  FLUORESCENCE SPECTRAL CHANGES OF HEMATOPORPHYRIN DERIVATIVE UPON BINDING TO LIPID VESICLES, Staphylococcus aureus AND Escherichia coli CELLS , 1985, Photochemistry and photobiology.

[31]  M. Wainwright Photoinactivation of viruses , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[32]  C. Gomer PRECLINICAL EXAMINATION OF FIRST and SECOND GENERATION PHOTOSENSITIZERS USED IN PHOTODYNAMIC THERAPY , 1991, Photochemistry and photobiology.

[33]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[34]  J Moan,et al.  Lysosomes and Microtubules as Targets for Photochemotherapy of Cancer , 1997, Photochemistry and photobiology.

[35]  Michael R. Detty,et al.  Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy , 2004 .

[36]  Michael T. Wilson Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infections , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[37]  Qian Peng,et al.  Milestones in the development of photodynamic therapy and fluorescence diagnosis , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[38]  T. Dougherty,et al.  MEMBRANE LYSIS IN CHINESE HAMSTER OVARY CELLS TREATED WITH HEMATOPORPHYRIN DERIVATIVE PLUS LIGHT , 1982, Photochemistry and photobiology.